Ursula Busse

Ursula Busse is the Head of Regulatory Affairs at Tigen Pharma, a Swiss biotech company specializing in developing autologous T-cell therapies for cancer treatment. In her current position, she is responsible for overseeing regulatory strategy and compliance, which is crucial for navigating the complexities of drug development and approval processes in the biotechnology sector.23

Before joining Tigen, Ursula held significant roles in regulatory affairs at other prominent organizations. Notably, she was the Head of Regulatory Intelligence and Policy at Boehringer Ingelheim from 2021 to 2022, and prior to that, she served in global regulatory roles from 2018 to 2021.4 Her extensive experience in regulatory affairs is complemented by her involvement in various advisory councils, including the Regional Advisory Council (RAC) and the Regulatory and Quality Advisory Board (RAQAB) .12

Ursula's academic background includes advanced degrees, specifically a PhD and an MBA, which enhance her expertise in both scientific and business aspects of biotechnology.3 Her professional journey reflects a strong commitment to advancing healthcare through effective regulatory practices.